2m 2m 2m 2m 2m 2m 2m
Ethema Health (GRST)
OTC
$0.0001+$0.00010 (+9,900.00%)
Price as of May 29, 2026- $772,628.00Market Cap
- -75.00%1-Year Change
- Medical Care FacilitiesIndustry
Ethema Health (GRST)
$0.0001+$0.00010 (+9,900.00%)
Annual
Quarterly
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 6.0M +12.58% | 5.3M +10.87% | 4.8M +148.16% | 1.9M +473.04% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 6.0M +12.58% | 5.3M +10.87% | 4.8M +148.16% | 1.9M +473.04% | |
Sales and Marketing Expense | 371,229 N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 466,952 -6.41% | 498,919 -7.63% | 540,119 +66.01% | 325,350 +168.27% | |
Total Operating Expenses | 7.4M +24.86% | 5.9M +35.90% | 4.3M +123.22% | 1.9M +286.29% | |
Operating Profit | -1.3M +146.00% | -541,920 -210.80% | 489,117 +23,135.96% | 2,105 +101.29% | |
Interest Income | 2,292 +239.05% | 676 +766.67% | 78 -93.80% | 1,258 +100.00% | |
Interest Expense | N/A N/A | N/A N/A | -205,133 -75.27% | -829,525 +31.37% | |
Interest Income and Expense and Net | 2,292 +239.05% | 676 +100.33% | -205,055 -75.24% | -828,267 +31.31% | |
Total Nonoperating Income and Expense | 110,000 +248.98% | 31,520 +100.00% | 15,760 -94.23% | 273,373 -56.71% | |
Income before Taxes | -2.2M -452.50% | 614,453 +50.82% | 407,408 +121.97% | -1.9M -161.16% | |
Income Taxes | N/A N/A | 391,962 +449.28% | -112,220 -60.05% | -280,903 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -2.1M -282.76% | 1.1M +355.61% | 247,880 +116.07% | -1.5M -150.01% | |
Net Income from Continuing Operations Applicable to Common | -2.1M -282.76% | 1.1M +652.42% | 150,098 +109.13% | -1.6M -154.20% | |
Basic EPS and Net Income | 0.00 N/A | N/A N/A | N/A N/A | N/A N/A | |
Diluted EPS and Net Income | 0.00 N/A | N/A N/A | N/A N/A | N/A N/A | |
Basic Weighted Average Shares | 5.6B N/A | N/A N/A | N/A N/A | N/A N/A | |
Diluted Weighted Average Shares | 5.6B N/A | N/A N/A | N/A N/A | N/A N/A | |
Balance Sheet | |||||
Cash and Cash Equivalents | 244,771 +256.95% | 68,573 -51.28% | 140,757 +188.31% | 48,822 -46.05% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 244,771 +256.95% | 68,573 -51.28% | 140,757 +188.31% | 48,822 -46.05% | |
Total Current Assets | 528,758 +31.17% | 403,100 -25.75% | 542,896 +99.74% | 271,799 -70.94% | |
Accumulated Depreciation | 137,330 -17.64% | 166,746 -78.57% | 778,195 +21.58% | 640,070 N/A | |
Property and Plant and Equipment and Net | 699,688 +37.63% | 508,401 -82.91% | 3.0M -1.27% | 3.0M -47.84% | |
Total Long-Term Assets | 11.6M +4.62% | 11.1M +84.64% | 6.0M -4.17% | 6.3M +117.59% | |
Total Assets | 12.2M +5.55% | 11.5M +75.51% | 6.6M +0.14% | 6.6M +71.47% | |
Income Taxes Payable | N/A N/A | N/A N/A | 248,644 -62.26% | 658,836 -22.52% | |
Total Short-Term Debt | 6.5M +28.38% | 5.1M -10.98% | 5.7M -23.89% | 7.5M +157.19% | |
Total Current Liabilities | 9.7M +16.34% | 8.3M -37.55% | 13.3M -1.68% | 13.5M -2.51% | |
Total Long-Term Debt | 405,000 N/A | N/A N/A | 3.5M -9.31% | 3.9M +0.42% | |
Total Long-Term Liabilities | 10.0M +5.75% | 9.4M +347.17% | 2.1M -15.49% | 2.5M -45.61% | |
Total Liabilities | 19.6M +10.71% | 17.7M +15.09% | 15.4M -3.83% | 16.0M -13.22% | |
Retained Earnings | -44.4M +4.87% | -42.4M -2.60% | -43.5M -1.40% | -44.1M +3.87% | |
Total Stockholders Equity | N/A N/A | -6.2M -38.63% | -10.1M -5.39% | -10.7M -32.10% | |
Total Shares Outstanding | 7.7B +107.27% | 3.7B 0.00% | 3.7B +4.19% | 3.6B +62.16% | |
Cash Flow | |||||
Cash from Operating Activities | -455,704 -14.04% | -530,157 -133.62% | 1.6M +1,943.09% | -85,567 -16.09% | |
Capital Expenditures | 60,259 +48.41% | 40,602 -87.14% | 315,822 +137.76% | 132,832 N/A | |
Cash from Investing Activities | -1.0M -141.09% | 2.5M +444.62% | -712,259 +24.29% | -573,045 -16.28% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 1.7M +180.66% | -2.1M -784.01% | 303,714 -48.54% | 590,195 -30.89% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -22.16% +118.52% | -10.14% -199.93% | 10.15% +9,259.87% | 0.11% +100.22% | |
Return on Assets | -17.43% -239.58% | 12.49% +230.52% | 3.78% +112.71% | -29.74% -133.90% | |
Return on Equity | N/A N/A | -13.85% +480.77% | -2.39% -120.41% | 11.69% +167.71% | |
Revenue Growth | 12.58% +15.66% | 10.87% -92.66% | 148.16% -68.68% | 473.04% +8,227.02% | |
Current Ratio | 0.05 +12.76% | 0.05 +18.83% | 0.04 +103.48% | 0.02 -70.18% | |
Cash Ratio | 0.03 +206.02% | 0.008 -21.70% | 0.01 +194.44% | 0.004 -44.62% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | -0.91 -14.33% | -1.07 +147.66% | |
Debt-to-Assets Ratio | 0.57 N/A | N/A N/A | 1.41 -19.05% | 1.74 -1.94% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow